Needelman Asset Management’s AbbVie ABBV Stock Holding History

Needelman Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-14,092	Closed	-$1.31M	–	2
2018 Q2	$1.31M	Hold	14,092	–	–	2.84%	18
2018 Q1	$1.33M	Buy	14,092 +4,070	+41%	+$447K	2.88%	17
2017 Q4	$969K	Sell	10,022 -35	-0.3%	-$3.3K	2.42%	24
2017 Q3	$894K	Hold	10,057	–	–	2.2%	25
2017 Q2	$729K	Sell	10,057 -75	-0.7%	-$5.04K	1.88%	34
2017 Q1	$660K	Sell	10,132 -50	-0.5%	-$3.14K	1.77%	34
2016 Q4	$638K	Hold	10,182	–	–	1.77%	34
2016 Q3	$642K	Hold	10,182	–	–	1.93%	33
2016 Q2	$630K	Hold	10,182	–	–	1.8%	33
2016 Q1	$582K	Hold	10,182	–	–	1.7%	34
2015 Q4	$603K	Sell	10,182 -35	-0.3%	-$2.02K	1.83%	33
2015 Q3	$556K	Hold	10,217	–	–	1.83%	32
2015 Q2	$686K	Hold	10,217	–	–	2.17%	28
2015 Q1	$598K	Sell	10,217 -5	-0%	-$302	1.82%	32
2014 Q4	$669K	Hold	10,222	–	–	2.05%	29
2014 Q3	$590K	Hold	10,222	–	–	1.89%	31
2014 Q2	$577K	Hold	10,222	–	–	1.82%	32
2014 Q1	$525K	Sell	10,222 -150	-1%	-$7.58K	1.71%	32
2013 Q4	$548K	Hold	10,372	–	–	1.81%	32
2013 Q3	$464K	Hold	10,372	–	–	1.66%	34
2013 Q2	$429K	Buy	+10,372	New	+$454K	1.57%	35

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Needelman Asset Management's ABBV Position: Q3 2018 in Review

Needelman Asset Management sold out of AbbVie (ABBV) in Q3 2018, closing a stake of 14,092 shares — an estimated $1.31M sold.

Needelman Asset Management first reported a position in ABBV in Q2 2013 and held it in 21 quarters. The position peaked at $1.33M in Q1 2018. 1,957 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

Needelman Asset Management reported no remaining AbbVie position as of Q3 2018 after selling out during the quarter.
Needelman Asset Management sold 14,092 AbbVie shares in Q3 2018, an estimated $1.31M.
Needelman Asset Management first reported a position in AbbVie in Q2 2013 and held it in 21 quarters.
Needelman Asset Management's AbbVie position peaked at $1.33M in Q1 2018.
1,957 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Needelman Asset Management's 13F filing for Q3 2018.